
Applied Energetics
Coming April 9, 2026
Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second

Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second

InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins

Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time

Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second

Ultrashort pulse lasers deliver intense bursts of energy and can destroy optical and infrared sensors on drones in less than a second

Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention

AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies

AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies

Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.

Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention

Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.

NextTrip (NASDAQ: NTRP) is a travel discovery and booking platform built to disrupt an industry that’s been stagnant for 30 years